• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Med. A study on infectivity of asymptomatic SARS-CoV-2 carriers

tetano

Editor, Senior Moderator
Respir Med. 2020 May 13:106026. doi: 10.1016/j.rmed.2020.106026. [Epub ahead of print]
A study on infectivity of asymptomatic SARS-CoV-2 carriers.


Gao M[SUP]1[/SUP], Yang L[SUP]2[/SUP], Chen X[SUP]3[/SUP], Deng Y[SUP]4[/SUP], Yang S[SUP]5[/SUP], Xu H[SUP]5[/SUP], Chen Z[SUP]5[/SUP], Gao X[SUP]5[/SUP].

Author information




Abstract

Background:

An ongoing outbreak of coronavirus disease 2019 (COVID-19) has spread around the world. It is debatable whether asymptomatic COVID-19 virus carriers are contagious. We report here a case of the asymptomatic patient and present clinical characteristics of 455 contacts, which aims to study the infectivity of asymptomatic carriers.
Material and methods:

455 contacts who were exposed to the asymptomatic COVID-19 virus carrier became the subjects of our research. They were divided into three groups: 35 patients, 196 family members and 224 hospital staffs. We extracted their epidemiological information, clinical records, auxiliary examination results and therapeutic schedules.
Results:

The median contact time for patients was four days and that for family members was five days. Cardiovascular disease accounted for 25% among original diseases of patients. Apart from hospital staffs, both patients and family members were isolated medically. During the quarantine, seven patients plus one family member appeared new respiratory symptoms, where fever was the most common one. The blood counts in most contacts were within a normal range. All CT images showed no sign of COVID-19 infection. No severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections was detected in 455 contacts by nucleic acid test.
Conclusion:

In summary, all the 455 contacts were excluded from SARS-CoV-2 infection and we conclude that the infectivity of some asymptomatic SARS-CoV-2 carriers might be weak.
? 2020 Published by Elsevier Ltd.



KEYWORDS:

Asymptomatic carrier; CDC, Chinese Center for Disease Control and Prevention; CHD, congenital heart disease; COVID-19, Coronavirus disease 2019; CT, computed tomography; Contacts; ED, emergency department; EDOU, emergency department observation unit; GCDC, Guangzhou Center for Disease Control and Prevention; IQR, interquartile ranges; Infectivity; PPE, personal protective equipment; RT-PCR, Reverse Transcription-Polymerase Chain Reaction; SARS-CoV-2; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2


PMID:32405162PMCID:PMC7219423DOI:10.1016/j.rmed.2020.106026
 
Back
Top Bottom